Article
Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Pediatric nephrology (Berlin, Germany) - 1 Sept 2008
Plank Christian, Kalb Veronica, Hinkes Bernward, Hildebrandt Friedhelm, Gefeller Olaf, Rascher Wolfgang
Abstract excerpt
First line immunosuppressive treatment in steroid-resistant nephrotic syndrome in children is still open to discussion. We conducted a controlled multicentre randomized open label trial to test the efficacy and safety of cyclosporin A (CSA) versus cyclophosphamide pulses (CPH) in the initial therapy of children with newly diagnosed primary steroid-resistant nephrotic syndrome and histologically proven minimal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
